Atlas Trials

Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors

Clinical trial NCT01149720 · COMPLETED

Trial details

NCT number
NCT01149720
Sponsor
Daiichi Sankyo
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2010-07-01
Primary completion
2011-03-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.